Fresenius Medical Care AG/€FME
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Fresenius Medical Care AG
Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.
Ticker
€FME
Sector
Primary listing
XETRA
Industry
Health Care Providers & Services
Headquarters
Employees
112,035
ISIN
DE0005785802
Website
FME Metrics
BasicAdvanced
€14B
22.28
€2.11
0.85
€1.44
3.07%
Price and volume
Market cap
€14B
Beta
0.85
52-week high
€54.02
52-week low
€32.51
Average daily volume
503K
Dividend rate
€1.44
Financial strength
Current ratio
1.461
Quick ratio
0.856
Long term debt to equity
61.316
Total debt to equity
69.79
Dividend payout ratio (TTM)
56.48%
Interest coverage (TTM)
3.91%
Profitability
EBITDA (TTM)
2,361.797
Gross margin (TTM)
24.46%
Net profit margin (TTM)
3.17%
Operating margin (TTM)
8.74%
Effective tax rate (TTM)
29.32%
Revenue per employee (TTM)
€170,000
Management effectiveness
Return on assets (TTM)
3.18%
Return on equity (TTM)
5.30%
Valuation
Price to earnings (TTM)
22.28
Price to revenue (TTM)
0.707
Price to book
0.89
Price to tangible book (TTM)
-29.56
Price to free cash flow (TTM)
8.093
Free cash flow yield (TTM)
12.36%
Free cash flow per share (TTM)
580.03%
Dividend yield (TTM)
3.07%
Forward dividend yield
3.07%
Growth
Revenue change (TTM)
0.10%
Earnings per share change (TTM)
27.83%
3-year revenue growth (CAGR)
2.77%
10-year revenue growth (CAGR)
2.43%
3-year earnings per share growth (CAGR)
-11.07%
10-year earnings per share growth (CAGR)
-4.09%
3-year dividend per share growth (CAGR)
2.17%
10-year dividend per share growth (CAGR)
5.13%
What the Analysts think about FME
Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.
Bulls say / Bears say
Fresenius Medical Care (FMC) reported stronger-than-expected first-quarter results in 2025, with revenues of €4.88 billion and adjusted operating income of €457 million, surpassing analysts' estimates. (reuters.com)
The company announced a €1 billion share buyback program and set a target to achieve a mid-teens operating income margin by 2030, indicating a strong commitment to shareholder returns and long-term profitability. (reuters.com)
FMC delivered an 18% earnings growth in 2024 and continues to accelerate momentum into 2025, demonstrating effective execution of its turnaround plan. (prnewswire.com)
In July 2024, FMC revised its expected growth in U.S. treatment volumes to flat or up to 0.5%, down from the previously expected 0.5% to 2%, due to high mortality rates among patients from COVID-19 and influenza. (reuters.com)
The company's overall operating income for the fourth quarter of 2024 decreased by 39% to €259 million, including one-off costs, despite an 8% increase in adjusted operating income. (reuters.com)
FMC's revenue slightly declined by 0.6% in 2024 compared to the previous year, indicating potential challenges in maintaining growth. (prnewswire.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.
FME Financial Performance
Revenues and expenses
FME Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Fresenius Medical Care AG stock?
Fresenius Medical Care AG (FME) has a market cap of €14B as of July 11, 2025.
What is the P/E ratio for Fresenius Medical Care AG stock?
The price to earnings (P/E) ratio for Fresenius Medical Care AG (FME) stock is 22.28 as of July 11, 2025.
Does Fresenius Medical Care AG stock pay dividends?
Yes, the Fresenius Medical Care AG (FME) stock pays dividends to shareholders. As of July 11, 2025, the dividend rate is €1.44 and the yield is 3.07%. Fresenius Medical Care AG has a payout ratio of 56.48% on a trailing twelve-month basis.
When is the next Fresenius Medical Care AG dividend payment date?
The next Fresenius Medical Care AG (FME) dividend payment date is unconfirmed.
What is the beta indicator for Fresenius Medical Care AG?
Fresenius Medical Care AG (FME) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.